Molecular Study of the Poly (ADP-ribose) Polymerase-1 Gene as a Promotor of Inflammation-Driven Colorectal Carcinoma
- 1Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- 2Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt. alshimaamagdy82@yahoo.com.
- 3Gastroenterology Surgical Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
- 0Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study found higher expression of PARP1 and NF-κB genes in colorectal cancer (CRC) tissues, suggesting potential therapeutic targets. These markers show promise for CRC diagnosis and may complement existing biomarkers.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- Chronic inflammation is a known risk factor for CRC, but underlying mechanisms remain unclear.
- Understanding inflammation's role in CRC pathogenesis is crucial for developing effective treatments.
Purpose Of The Study
- To investigate the mRNA expression levels of PARP1 and NF-κB/p50 in colorectal cancer.
- To elucidate the role of PARP1 and NF-κB in inflammation-driven CRC.
- To define stage-specific expression patterns of PARP1 and NF-κB in CRC.
Main Methods
- Analysis of 35 CRC tissue samples and 25 healthy controls.
- Quantification of PARP1 and NF-κB/p50 mRNA using reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
- Assessment of gene expression correlation and diagnostic accuracy (AUC).
Main Results
- PARP1 and NF-κB/p50 mRNA expression were significantly elevated in CRC tissues compared to controls.
- A positive correlation was observed between PARP1 and NF-κB/p50 mRNA levels, with PARP1 explaining 14.5% of the variation in NF-κB/p50.
- Both markers demonstrated high diagnostic accuracy for CRC (AUC=0.905 for PARP1, AUC=0.956 for NF-κB/p50).
Conclusions
- Overexpression of PARP1 and NF-κB suggests their involvement in CRC pathogenesis.
- PARP1 inhibitors and anti-inflammatory drugs may hold therapeutic potential for CRC.
- PARP1 and NF-κB warrant further investigation as diagnostic and prognostic markers for CRC.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
03:18
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...

